FdaApplication
ANDA 216346
Identifiers
- fda_app_no: ANDA216346
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL EU LTD |
| application_type | ANDA |
| approval_date | 2023-04-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NELARABINE | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
1 product